Literature DB >> 16853398

Physical stability and relaxation of amorphous indomethacin.

Sergey Vyazovkin1, Ion Dranca.   

Abstract

The alpha- and beta-relaxation processes in amorphous indomethacin have been studied by using differential scanning calorimetry. The beta-process has been detected as a small endothermic peak that emerges before the glass transition step when reheating samples previously annealed in the temperature region -20 to +5 degrees C. The activation energy of the beta-process is approximately 57 kJ mol(-1), and shows an increase with increasing temperature as it approaches the glass transition region. In the glass transition region, the effective activation energy of relaxation decreases with increasing temperature from 320 to 160 kJ mol(-1). Heat capacity measurements have allowed for the evaluation of the cooperatively rearranging region in terms of the linear size (3.4 nm) and the number of molecules (90). The beta-relaxation fades below -30 degrees C, which provides a practical estimate for the lower temperature limit of physical instability in indomethacin. It is demonstrated experimentally that nucleation of indomethacin takes place in the temperature region of the beta-relaxation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16853398     DOI: 10.1021/jp052985i

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  10 in total

1.  Using thermally stimulated current (TSC) to investigate disorder in micronized drug substance produced at different milling energies.

Authors:  Rachel Forcino; Jeffrey Brum; Marc Galop; Yan Sun
Journal:  Pharm Res       Date:  2010-08-10       Impact factor: 4.200

2.  Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation.

Authors:  George Z Papageorgiou; Dimitrios Bikiaris; Evagelos Karavas; Stavros Politis; Aristides Docoslis; Yong Park; Anagnostis Stergiou; Emmanouel Georgarakis
Journal:  AAPS J       Date:  2006-10-06       Impact factor: 4.009

3.  Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.

Authors:  Chandan Bhugra; Rama Shmeis; Steven L Krill; Michael J Pikal
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

4.  Molecular motions in sucrose-PVP and sucrose-sorbitol dispersions-II. Implications of annealing on secondary relaxations.

Authors:  Sisir Bhattacharya; Sunny P Bhardwaj; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

5.  Surface crystallization of indomethacin below Tg.

Authors:  Tian Wu; Lian Yu
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

6.  Probing beta relaxation in pharmaceutically relevant glasses by using DSC.

Authors:  Sergey Vyazovkin; Ion Dranca
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

7.  Implications of global and local mobility in amorphous sucrose and trehalose as determined by differential scanning calorimetry.

Authors:  Ion Dranca; Sisir Bhattacharya; Sergey Vyazovkin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

8.  Effects of Glass Transition and Structural Relaxation on Crystal Nucleation: Theoretical Description and Model Analysis.

Authors:  Jürn W P Schmelzer; Timur V Tropin; Vladimir M Fokin; Alexander S Abyzov; Edgar D Zanotto
Journal:  Entropy (Basel)       Date:  2020-09-29       Impact factor: 2.524

9.  Ionic liquids and their bases: Striking differences in the dynamic heterogeneity near the glass transition.

Authors:  K Grzybowska; A Grzybowski; Z Wojnarowska; J Knapik; M Paluch
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

Review 10.  Activation Energies and Temperature Dependencies of the Rates of Crystallization and Melting of Polymers.

Authors:  Sergey Vyazovkin
Journal:  Polymers (Basel)       Date:  2020-05-07       Impact factor: 4.329

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.